# Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide

> **NCT02170519** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 27 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Inhaled Iloprost

## Key facts

- **NCT ID:** NCT02170519
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Project was completed
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170519, "Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02170519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*